Scarica l'app Stockscreener
4.13
0.24%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Barron's lists USD 7.00 target for Oramed Pharmaceuticals stock - AD HOC NEWS
Oramed Pharmaceuticals Inc (OJU1.DU) stock price, news, quote and history - Yahoo Finance UK
Oramed Pharmaceuticals schedules November 12 results for Oramed Pharmaceuticals stock - ad-hoc-news.de
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Oramed Pharmaceuticals stock fell 3.74 percent as targets rose - AD HOC NEWS
Oramed Pharmaceuticals Inc (OJU1.DU) stock price, news, quote and history - Yahoo Finance Australia
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com Australia
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals (ORMP) CFO Avraham Gabay Sells 20,000 Sha - GuruFocus
Oramed COO & CBO Joshua Hexter sells $135,330 in shares By Investing.com - Investing.com Nigeria
Oramed COO & CBO Joshua Hexter sells $135,330 in shares By Investing.com - Investing.com South Africa
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com India
Oramed COO & CBO Joshua Hexter sells $135,330 in shares - Investing.com
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock - Investing.com
A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. - Stock Titan
Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. - Stock Titan
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com UK
Form 144 ORAMED PHARMACEUTICALS INC. For: 1 October By Investing.com - Investing.com Nigeria
Form 144 ORAMED PHARMACEUTICALS INC. For: 1 October By Investing.com - Investing.com Canada
An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. - Stock Titan
A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). - Stock Titan
40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. - Stock Titan
Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. - Stock Titan
Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to S&P Global BMI Index - marketscreener.com
Oramed Pharmaceuticals stock trades quietly as investors weigh recent trial progress - AD HOC NEWS
Oramed Pharmaceuticals Inc.Common Stock (Nasdaq:ORMP) Detailed Stock Data - The Chronicle-Journal
Form 8K Oramed Pharmaceuticals Inc For: 17 September By Investing.com - Investing.com Nigeria
Form 8K Oramed Pharmaceuticals Inc For: 17 September By Investing.com - Investing.com UK
Oramed Pharmaceuticals (ORMP) moves to three-year pay votes - Stock Titan
Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting - Investing.com
Oramed shifts focus to investments, sees gains but faces cash and dilution risks - Pluang
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha
Oramed Pharmaceuticals (ORMP) Slips to $4.76, Holding Above $4.52 SupportIV Rank - careplusvn.com
Oramed backs exoskeleton maker Lifeward (NASDAQ: LFWD) in milestone-based funding deal - Stock Titan
Oramed Pharmaceuticals (ORMP) Rises 3.2% to $5.0, Testing Key $5.25 ResistanceTPO Profile - vinanet.vn
Oramed Pharmaceuticals (ORMP) Rises 3.2% to $5.0, Testing Key $5.25 ResistanceConversion Trade - siam.in
Oramed Pharmaceuticals stock holds at $5 after recent biotech volatility - ad-hoc-news.de
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness - Yahoo Finance
Biotech Stocks At 52-Week HighsNEO, BLSM, RVMD, ORMP, CADL - RTTNews
Oramed Pharmaceuticals Incorporated Actuals & Estimates (TRADEGATE:OJU1) - TradingView
Top Penny Stocks To Watch In August 2026 - simplywall.st
Top Penny Stocks To Watch In August 2026 - simplywall.st
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the DayDividend Earnings Report - vinanet.vn
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the DayMid-Term Outlook - dars.gov.et
Nano Dimension Names Nadav Kidron to Board, Exclusivity with Infinite Epigenetics Ends - Kalkine Media
Nano Dimension Appoints Nadav Kidron to Lead Capital Allocation Review - citybiz
Oramed CEO Joins Nano Dimension Board as Directors Weigh Capital Options - Stock Titan
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee - Yahoo Finance
ORMP Price Today: Oramed Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC
3.09%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):